Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function?
Stefanini
G F
GF
Addolorato
G
G
Caputo
F
F
Bernardi
M
M
Gasbarrini
G
G
D004338:Drug Combinations; D005235:Fatty Liver, Alcoholic / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D008111:Liver Function Tests; D011736:Pyridoxine / Q000627:therapeutic use*; D011761:Pyrrolidonecarboxylic Acid / Q000627:therapeutic use*
D004338:Drug Combinations; D006885:Hydroxybutyrates; C111420:4-hydroxybutyric acid; C037845:metadoxine; D011736:Pyridoxine; D011761:Pyrrolidonecarboxylic Acid